Clinical Trial

Angiotensin Receptor Blockers in Aortic Stenosis

Name: Angiotensin Receptor Blockers in Aortic Stenosis — clinical trial record (NCT04913870)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ARBAS

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This study is intended to investigate the effect of angiotensin receptor blockers (ARBs) on mild-to-moderate aortic stenosis.

Protocol Amendment History 5 amendments

This ClinicalTrials.gov record has been amended 5 times since 2021-05-27; most recent amendment 2024-12-18.

Trial Details

NCT Number	NCT04913870
Lead Sponsor	Institut universitaire de cardiologie et de pneumologie de Québec, University Laval Collaborators: Odense University Hospital
Conditions	Aortic Stenosis, Aortic Valve Stenosis
Enrollment	144 participants
Start Date	2020-02-01
Primary Completion	2027-02 (estimated)
Study Completion	2027-02 (estimated)
Updated on ClinicalTrials.gov	2024-12-20